FDA approves new oral antibiotic for uncomplicated urinary tract infections in women with limited treatment options. Orylnvah shows superior response rates ...
Caregiver adverse childhood experiences were related to pediatric health outcomes, such as antibiotic prescribing and time to first infection-related clinical encounter.
The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.
Mycoplasma pneumoniae, also known as walking pneumonia, is generally a mild bacterial infection that largely affects children and teens and can commonly be treated with antibiotics. M. pneumoniae ...